Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2003 Apr 29;88(9):1445–1452. doi: 10.1038/sj.bjc.6600867

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2003 Cancer Research UK

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

MMPI (A-177430) and COX-2I (A-285969) cooperate to reduce tumour multiplicity in Min mice. Single-dose study (A) involved treatment of Min mice at 5–6 weeks for 45 days with twice daily i.p. injections of vehicle (HPMC, n=3), a broad-spectrum MMPI (A-177430, n=6), a COX-2I (A-285969, n=5), or an NSAID (sulindac, n=6) at the doses indicated. ^*Denotes statistically significant difference between individual treatment groups and the vehicle-treated group. Combination study (B) repeated the above regimen using suboptimal doses alone and in combination as indicated. Each bar is representative of the total number of mice in the experiment where vehicle n=5, COX-2I n=5, MMPI n=6, and combination n=6. Statistical differences were calculated as described in Materials and Methods by comparing vehicle and treated groups ^*P=0.0367, ^**P=0.009, ^***P=0.0062 or the combination-treated group and individual treatment groups. ^‡P=0.0062. Tumour size (C) was determined as described in Materials and Methods.